SCHEMBL417089

SCHEMBL417089

C[N+](C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16858636 0.78
Nitromethane SCHEMBL525 0.72
SCHEMBL8622641 0.72
SCHEMBL2723129 0.72
Nitromethane SCHEMBL8771927 0.68
Nitromethane SCHEMBL10735049 0.68
Nitromethane SCHEMBL17162023 0.68
Nitromethane SCHEMBL1890507 0.68
Nitromethane SCHEMBL8204968 0.68
Nitromethane SCHEMBL8528126 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010050918-A1 BRANCHED CHAIN DETERGENTS FOR MEMBRANE PROTEIN STRUCTURAL BIOLOGY ZHANG QINGHAI (US) 2010-05-06 WO claimed
CN-114585718-A Storage-stable hydrolases-containing liquids 巴斯夫欧洲公司 2022-06-03 CN disclosed
US-20170275246-A1 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR METABASIS THERAPEUTICS, INC. 2017-09-28 US disclosed
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 US disclosed
US-9701626-B2 Antagonists of the glucagon receptor METABASIS THERAPEUTICS, INC. (US) 2017-07-11 US disclosed
US-20170029372-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-02-02 US disclosed
US-20170029372-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-02-02 US disclosed
US-9443661-B2 Power storage device having a nitroxyl polymer in a cathode and a lithium or lithium alloy anode NEC CORPORATION (JP) 2016-09-13 US disclosed
US-20160009639-A1 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR METABASIS THERAPEUTICS INC (US) 2016-01-14 US disclosed
US-20150313898-A1 COMPOUNDS THAT INHIBIT HUMAN DNA LIGASES AND METHODS OF TREATING CANCER NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-11-05 US disclosed
WO-2010050918-A1 BRANCHED CHAIN DETERGENTS FOR MEMBRANE PROTEIN STRUCTURAL BIOLOGY ZHANG QINGHAI (US) 2010-05-06 WO disclosed
US-20090274947-A1 Imidazolidinone nitroxides as electrode materials for energy storage devices CIBA CORP. 2009-11-05 US disclosed
US-20080305118-A1 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2008-12-11 US disclosed
US-20080297350-A1 Rfid Tag NEC CORPORATION (JP) 2008-12-04 US disclosed
US-20080259680-A1 Memory Element and Method for Manufacturing Same WASEDA UNIVERSITY (JP) 2008-10-23 US disclosed
US-20080213669-A1 Power Storage Device NEC CORPORATION (JP) 2008-09-04 US disclosed
US-20070129553-A1 Process for the preparation of glyceraldehyde acetonide DSM IP ASSETS B.V. (NL) 2007-06-07 US disclosed
US-20060073216-A1 Compositions and methods for control of bovine mastitis SOLUTION BIOSCIENCES, INC. 2006-04-06 US disclosed
WO-2004057966-A1 COMPOSITIONS AND METHODS FOR CONTROL OF BOVINE MASTITIS SOLUTION BIOSCIENCES, INC. (US) 2004-07-15 WO disclosed
US-4446153-A BENZYL ALCOHOL, PHENETHYL ALCOHOL RALSTON PURINA COMPANY (US) 1984-05-01 US disclosed